These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33848466)

  • 1. Attitudes of US adults toward using telemedicine to prescribe medication abortion during COVID-19: A mixed methods study.
    LaRoche KJ; Jozkowski KN; Crawford BL; Haus KR
    Contraception; 2021 Jul; 104(1):104-110. PubMed ID: 33848466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "It was close enough, but it wasn't close enough": A qualitative exploration of the impact of direct-to-patient telemedicine abortion on access to abortion care.
    Kerestes C; Delafield R; Elia J; Chong E; Kaneshiro B; Soon R
    Contraception; 2021 Jul; 104(1):67-72. PubMed ID: 33933421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models.
    Kerestes C; Murayama S; Tyson J; Natavio M; Seamon E; Raidoo S; Lacar L; Bowen E; Soon R; Platais I; Kaneshiro B; Stowers P
    Contraception; 2021 Jul; 104(1):49-53. PubMed ID: 33789080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Greasing the wheels: The impact of COVID-19 on US physician attitudes and practices regarding medication abortion.
    Karlin J; Sarnaik S; Holt K; Dehlendorf C; Joffe C; Steinauer J
    Contraception; 2021 Sep; 104(3):289-295. PubMed ID: 33932400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes to medication abortion clinical practices in response to the COVID-19 pandemic.
    Tschann M; Ly ES; Hilliard S; Lange HLH
    Contraception; 2021 Jul; 104(1):77-81. PubMed ID: 33894247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Federal, state, and institutional barriers to the expansion of medication and telemedicine abortion services in Ohio, Kentucky, and West Virginia during the COVID-19 pandemic.
    Mello K; Smith MH; Hill BJ; Chakraborty P; Rivlin K; Bessett D; Norris AH; McGowan ML
    Contraception; 2021 Jul; 104(1):111-116. PubMed ID: 33930382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Efficacy of Telehealth Medication Abortions in the US During the COVID-19 Pandemic.
    Upadhyay UD; Koenig LR; Meckstroth KR
    JAMA Netw Open; 2021 Aug; 4(8):e2122320. PubMed ID: 34427682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The perspective of Canadian health care professionals on abortion service during the COVID-19 pandemic.
    Ennis M; Wahl K; Jeong D; Knight K; Renner R; Munro S; Dunn S; Guilbert E; Norman WV
    Fam Pract; 2021 Aug; 38(Suppl 1):i30-i36. PubMed ID: 34448482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family Physicians' Role in Simplifying Medication Abortion During the COVID-19 Pandemic.
    Patel P; Narayana S; Thill Z; Gold M; Paul A
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S33-S36. PubMed ID: 33622815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with successful implementation of telehealth abortion in 4 United States clinical practice settings.
    Godfrey EM; Fiastro AE; Jacob-Files EA; Coeytaux FM; Wells ES; Ruben MR; Sanan SS; Bennett IM
    Contraception; 2021 Jul; 104(1):82-91. PubMed ID: 33932401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication Abortion Provided Through Telemedicine in Four U.S. States.
    Kohn JE; Snow JL; Simons HR; Seymour JW; Thompson TA; Grossman D
    Obstet Gynecol; 2019 Aug; 134(2):343-350. PubMed ID: 31306317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abortion experiences and preferences of transgender, nonbinary, and gender-expansive people in the United States.
    Moseson H; Fix L; Ragosta S; Forsberg H; Hastings J; Stoeffler A; Lunn MR; Flentje A; Capriotti MR; Lubensky ME; Obedin-Maliver J
    Am J Obstet Gynecol; 2021 Apr; 224(4):376.e1-376.e11. PubMed ID: 32986990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United States.
    Raymond E; Chong E; Winikoff B; Platais I; Mary M; Lotarevich T; Castillo PW; Kaneshiro B; Tschann M; Fontanilla T; Baldwin M; Schnyer A; Coplon L; Mathieu N; Bednarek P; Keady M; Priegue E
    Contraception; 2019 Sep; 100(3):173-177. PubMed ID: 31170384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and preferences toward the provision of medication abortion in an urban academic internal medicine practice.
    Page C; Stumbar S; Gold M
    J Gen Intern Med; 2012 Jun; 27(6):647-52. PubMed ID: 22223135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "We've got rights and yet we don't have access": Exploring patient experiences accessing medication abortion in Australia.
    LaRoche KJ; Wynn LL; Foster AM
    Contraception; 2020 Apr; 101(4):256-260. PubMed ID: 31927029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "I just was really scared, because it's already such an uncertain time": Exploring women's abortion experiences during the COVID-19 pandemic in Canada.
    Hukku S; Ménard A; Kemzang J; Hastings E; Foster AM
    Contraception; 2022 Jun; 110():48-55. PubMed ID: 35123980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study of abortion care providers' perspectives on telemedicine medical abortion provision in the context of COVID-19.
    Reynolds-Wright JJ; Boydell N; Cameron S; Harden J
    BMJ Sex Reprod Health; 2022 Jul; 48(3):199-204. PubMed ID: 34848554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demand for self-managed online telemedicine abortion in eight European countries during the COVID-19 pandemic: a regression discontinuity analysis.
    Aiken ARA; Starling JE; Gomperts R; Scott JG; Aiken CE
    BMJ Sex Reprod Health; 2021 Oct; 47(4):238-245. PubMed ID: 33431614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes Toward Using COVID-19 mHealth Tools Among Adults With Chronic Health Conditions: Secondary Data Analysis of the COVID-19 Impact Survey.
    Camacho-Rivera M; Islam JY; Rivera A; Vidot DC
    JMIR Mhealth Uhealth; 2020 Dec; 8(12):e24693. PubMed ID: 33301415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. US clinicians' perspectives on how mifepristone regulations affect access to medication abortion and early pregnancy loss care in primary care.
    Srinivasulu S; Yavari R; Brubaker L; Riker L; Prine L; Rubin SE
    Contraception; 2021 Jul; 104(1):92-97. PubMed ID: 33910031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.